Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claude Chelala

Showing results (71-80 of 117) with videos related to

Pageof 12
Sort By:
European Journal of Human Genetics : EJHG|May 18, 2017
Recurrent somatic JAK-STAT pathway variants within a RUNX1-mutated pedigreeKiran Tawana, Jun Wang, Péter A Király, et al.
Genome Medicine|January 15, 2015
A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinomaSyed Haider, Jun Wang, Ai Nagano, et al.
Gastroenterology|July 30, 2013
Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinomaAbasi Ene-Obong, Andrew J Clear, Jennifer Watt, et al.
Omics : a Journal of Integrative Biology|September 5, 2014
Transcription-mediated chimeric RNAs in prostate cancer: time to revisit old hypothesis?Guoping Ren, Yanling Zhang, Xueying Mao, et al.
Cell Death & Disease|October 24, 2019
MLH1 deficiency leads to deregulated mitochondrial metabolismSukaina Rashid, Marta O Freitas, Danilo Cucchi, et al.
Frontiers in Oncology|November 4, 2015
Association between CLN3 (Neuronal Ceroid Lipofuscinosis, CLN3 Type) Gene Expression and Clinical Characteristics of Breast Cancer PatientsJoelle Makoukji, Mohamad Raad, Katia Genadry, et al.
Future Oncology (London, England)|August 20, 2016
Pancreatic cancer tissue banks: where are we heading?Vickna Balarajah, Archana Ambily, Abu Z Dayem Ullah, et al.
Pharmacological Reports : PR|May 17, 2023
Correction: A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesotheliomaMelissa M Phillips, Iuliia Pavlyk, Michael Allen, et al.
The Journal of Pathology|February 23, 2011
Clinical and functional significance of α9β1 integrin expression in breast cancer: a novel cell-surface marker of the basal phenotype that promotes tumour cell invasionMichael D Allen, Reza Vaziri, Michael Green, et al.
Pharmacological Reports : PR|April 3, 2023
A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesotheliomaMelissa M Phillips, Iuliia Pavlyk, Michael Allen, et al.
Pageof 12

Showing results (71-80 of 117) with videos related to

Sort By:
Pageof 12
European Journal of Human Genetics : EJHG|May 18, 2017
Recurrent somatic JAK-STAT pathway variants within a RUNX1-mutated pedigreeKiran Tawana, Jun Wang, Péter A Király, et al.
Genome Medicine|January 15, 2015
A multi-gene signature predicts outcome in patients with pancreatic ductal adenocarcinomaSyed Haider, Jun Wang, Ai Nagano, et al.
Gastroenterology|July 30, 2013
Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinomaAbasi Ene-Obong, Andrew J Clear, Jennifer Watt, et al.
Omics : a Journal of Integrative Biology|September 5, 2014
Transcription-mediated chimeric RNAs in prostate cancer: time to revisit old hypothesis?Guoping Ren, Yanling Zhang, Xueying Mao, et al.
Cell Death & Disease|October 24, 2019
MLH1 deficiency leads to deregulated mitochondrial metabolismSukaina Rashid, Marta O Freitas, Danilo Cucchi, et al.
Frontiers in Oncology|November 4, 2015
Association between CLN3 (Neuronal Ceroid Lipofuscinosis, CLN3 Type) Gene Expression and Clinical Characteristics of Breast Cancer PatientsJoelle Makoukji, Mohamad Raad, Katia Genadry, et al.
Future Oncology (London, England)|August 20, 2016
Pancreatic cancer tissue banks: where are we heading?Vickna Balarajah, Archana Ambily, Abu Z Dayem Ullah, et al.
Pharmacological Reports : PR|May 17, 2023
Correction: A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesotheliomaMelissa M Phillips, Iuliia Pavlyk, Michael Allen, et al.
The Journal of Pathology|February 23, 2011
Clinical and functional significance of α9β1 integrin expression in breast cancer: a novel cell-surface marker of the basal phenotype that promotes tumour cell invasionMichael D Allen, Reza Vaziri, Michael Green, et al.
Pharmacological Reports : PR|April 3, 2023
A role for macrophages under cytokine control in mediating resistance to ADI-PEG20 (pegargiminase) in ASS1-deficient mesotheliomaMelissa M Phillips, Iuliia Pavlyk, Michael Allen, et al.
Pageof 12